Angélica Figueroa
8PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 20, 2025
Beyond destruction: emerging roles of the E3 ubiquitin ligase Hakai.Juan-José Escuder-Rodríguez, Andrea Rodríguez-Alonso, Lía Jove
|Feb 10, 2024
Stratification of Colorectal Patients Based on Survival Analysis Shows the Value of Consensus Molecular Subtypes and Reveals the CBLL1 Gene as a Biomarker of CMS2 Tumours.Gloria Alfonsín, Alberto Berral-González, Andrea Rodríguez-Alonso
|Feb 25, 2022
Protein Degradation by E3 Ubiquitin Ligases in Cancer Stem Cells.Macarena Quiroga, Andrea Rodríguez-Alonso, Gloria Alfonsín
|May 18, 2021
Cancer drug resistance induced by EMT: novel therapeutic strategies.Javier De Las Rivas, Anamaria Brozovic, Sivan Izraely
|Oct 29, 2020
Regulation of Epithelial-Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer.Andrea Rodríguez-Alonso, Alba Casas-Pais, Daniel Roca-Lema
|May 28, 2020
Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression.Olaia Martinez-Iglesias, Alba Casas-Pais, Raquel Castosa
Pageof 2
Frequent Collaborators
1 joint publications
María-Esperanza Cerdán
1 joint publications
Federico Gago
1 joint publications
Alberto Berral-González
1 joint publications
Javier De Las Rivas
1 joint publications
Juan-José Escuder-Rodríguez
1 joint publications
Andrea Rodríguez-Alonso
1 joint publications
Lía Jove
1 joint publications
Macarena Quiroga
1 joint publications
Gloria Alfonsín
